Detriferol (Cholecalciferol) drops for oral administration 1500ME
31214USD

Detriferol (Cholecalciferol) drops for oral administration 1500ME

SKU:2099
To favorites
Vitamin D is involved in the functioning of the immune system, prevents autoimmune diseases, type 1 diabetes, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease
Active substance:Cholecalciferol
Pharmacological group:Vitamins
Formulation:drops
Dosage mg:1500
In stock
In stock
In stock
$12
11
Description
Features
Reviews

Detriferol (Cholecalciferol) drops for oral administration 1500ME

English product name
DeTriFerol

Release form
Infusion drops

Description Detriferol: 

Drops for absorption, with aniseed taste, with banana taste in the form of transparent or slightly opalescent, colorless or lightly colored liquid with a characteristic smell

1 ml
colecalciferol. D3) 15000 IU (0.375 mg)
Auxiliary substances: propylene glycol - 100 mg, macrogol glyceryl hydroxystearate - 50 mg, methylparahydroxybenzoate - 1 mg, sodium saccharinate - 0.7 mg, aromatizator anise - 0.7 mg, sodium hydrophosphate dihydrate - 3 mg, citric acid anhydrous - 0.6 mg, water d/i - up to 1 ml.

× with drip plug and screw-on cover with child protection mechanism or without child protection mechanism.

ATC codes
A11CC05 Colecalciferol

Clinical-pharmacological groups / Group affiliation
Preparation regulating the exchange of calcium and phosphorus

Active substance
colecalciferol. D)

Pharmacotherapy group
Vitamin D and its analogues

Storage Conditions
The drug Cholecalciferol should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.

Best before date
Shelf life is 3 years. Do not apply after expiration date.

Testimony Detriferol:

  • Prevention of vitamin D deficiency and diseases related to vitamin deficiency 
  • (rickets, osteomalations);
  • treatment of rickets;
  • complex therapy of osteoporosis of different genesis.

Method of use, course and dosage:

Oral.
The preparation is taken in a spoonful of liquid.
1 drop contains about 500 IU of vitamin D3.

Prevention of rickets
Newborns with four weeks of life - one drop (500 IU)/day.
Premature babies from four weeks of life - two drops (1000 IU)/day during the first year of life, then 1 drop (500 IU)/day.
The drug Cholecalciferol is used during the first two years of a child's life, in periods of low insolation (especially in winter).

Treatment of rickets
In the absence of visible deformities of the bone system (mild rickets) - two to three drops (1000-1500 IU)/day, treatment continue for 30 days.

In the presence of deformations of the bone system typical for rickets of medium and severe degree - four - eight drops (2000-4000 IU) / day. Treatment should last for 30-45 days. The dose of the drug Cholecalciferol and the duration of the therapy depend on the severity of the changes and are determined by the doctor (see "Special Instructions").

Prevention of vitamin D deficiency and diseases related to vitamin D deficiency (osteomalacia)
1 drop (500 IU)/day for the entire period of vitamin D deficiency. The minimum duration of the prophylaxis course is one month.

In complex treatment of osteoporosis
One to two drops (500-1000 IU)/day for three months. Reintroduction of therapy courses is possible on the recommendation of the doctor, depending on the results of the evaluation of bone and calcium exchange markers (see section "Special instructions")

Application in elderly patients Detriferol
Use with caution in elderly patients to avoid the risk of exacerbating chronic diseases.

Use in children Cholecalciferol
Use in children under 4 weeks is contraindicated.

  • Nosology Detriferol (ICD codes)
  • E55
  • Vitamin D deficiency
  • E55.0
  • Rickets active
  • M80.0
  • Postmenopausal osteoporosis with pathological fracture
  • M80.1
  • Osteoporosis with pathological fracture after ovarian removal
  • M80.4
  • Drug Cholecalciferol osteoporosis with pathological fracture
  • M80.5
  • Idiopathic osteoporosis with pathological fracture
  • M80.8
  • Another osteoporosis with a pathological fracture
  • M81.0
  • Postmenopausal osteoporosis
  • M81.1
  • Osteoporosis after ovarian removal
  • M81.4
  • Drug osteoporosis
  • M81.5
  • Idiopathic osteoporosis
  • M81.8
  • Other osteoporosis (senile osteopause)
  • M82
  • Osteoporosis in diseases classified in other rubrics
  • M83
  • Osteomalacia in adults

Pharmacological effect Detriferol:

Vitamin D3 is a natural form of vitamin D that is produced in the skin by the sun. Vitamin D2 is 25% more active than vitamin D2.
Vitamin D3 is an active anti-richitic factor. The most important function of vitamin D3 is the regulation of calcium and phosphate metabolism, which promotes proper mineralization and skeletal growth.
Colecalciferol plays a significant role in the absorption of calcium and phosphates in the gut, in the transport of mineral salts and in the process of bone calcification, and regulates the removal of calcium and phosphates by the kidneys.
Concentration of calcium ions in blood causes maintenance of skeletal muscle tone, myocardial function, promotes nervous excitement, regulates blood clotting process.

Features
Active substance
Pharmacological group
Formulation
Dosage mg
Country of origin
Brand
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating